TY  - JOUR 
AU  - Reboredo, Mercedes
AU  - Chang, Haisul C. Y.
AU  - Barbero, Roberto
AU  - Rodríguez-Ortigosa, Carlos M
AU  - Pérez-Vizcaíno, Francisco
AU  - Morán Benito, Asunción
AU  - García Domingo, Mónica
AU  - Banales, Jesus M.
AU  - Carreño, Norberto
AU  - Alegre, Félix
AU  - Herrero, Ignacio
AU  - Quiroga, Jorge
AU  - Prieto, Jesús
AU  - Sangro, Bruno
PY  - 2013
UR  - http://hdl.handle.net/10366/160607
AB  - Only a limited proportion of patients needing pharmacological control of portal hypertension are hemodynamic responders to propranolol. Here we analyzed the effects of zolmitriptan on portal pressure and its potential interaction with...
LA  - eng
KW  - Zolmitriptan
KW  - Portal hypertension
KW  - Haemodynamic parameters
KW  - Beta-blockers
KW  - Oxazolidinones
KW  - Portal Pressure
KW  - Body Weight
KW  - Common Bile Duct
KW  - Ligation
KW  - Liver Cirrhosis
KW  - Cyclic AMP
KW  - Propranolol
KW  - Splanchnic Circulation
KW  - Tryptamines
KW  - Vasodilation
KW  - Adrenergic beta-Antagonists
KW  - Drug Synergism
KW  - Drug Therapy
KW  - Carbon Tetrachloride
KW  - Catecholamines
KW  - Hypertension
KW  - Lypressin
KW  - Perfusion
KW  - Regional Blood Flow
KW  - Rats
KW  - Animals
KW  - Renal Artery
KW  - Sympathectomy
KW  - Antihypertensive Agents
TI  - Zolmitriptan: a novel portal hypotensive agent which synergizes with propranolol in lowering portal pressure.
DO  - 10.1371/journal.pone.0052683
VL  - 8
M2  - e52683
ER  -